|
News for Healthier Living
Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-Approved MI Cancer Seek(r)
Caris Life Sciences(r) (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, has published a study in Oncotarget validating the analytical and clinical performance of MI Cancer Seek(r).
August 15, 2025
August 15 2025August 14 2025August 13 2025August 12 2025August 11 2025August 10 2025August 9 2025August 8 2025August 7 2025August 6 2025August 5 2025August 4 2025August 3 2025August 2 2025
|
|
|
|
|